ASA Physical Status Classification
ASA Physical Status Classification
The ASA (American Society of Anesthesiologists) physical status classification has been
shown to generally correlate with the perioperative mortality rate (mortality rates given below).
ASA 2: a patient with a mild systemic disease (mild diabetes, controlled hypertension, obesity
[0.27-0.4%]).
ASA 3: a patient with a severe systemic disease that limits activity (angina, COPD, prior
myocardial infarction [1.8-4.3%]).
ASA 4: a patient with an incapacitating disease that is a constant threat to life (CHF, renal
failure [7.8-23%]).
ASA 5: a moribund patient not expected to survive 24 hours (ruptured aneurysm [9.4-51%]).
1. E.C.G. monitoring
2. Pulse oximetery monitoring
3. Capnography monitoring
4. Temperature monitoring
5. BP (NIBP or arterial line) monitoring
Absolute
• Patient refusal
• Inadequate resuscitation drugs and equipment
• Coagulopathy and Therapeutic anticoagulation (Thrombocytopenia: platelet count
below of 100,000/mm3 or INR <1.5)
• Skin infection at injection site.
• Raised intracranial pressure.
• Hypovolaemia.
• Septicaemia.
Relative
• Uncooperative patients
• Pre-existing neurological disorders
• Fixed cardiac output states.. This includes aortic stenosis, hypertrophic obstructive
cardiomyopathy (HOCM), mitral stenosis and complete heart block. Patients with these
cardiovascular abnormalities are unable to increase their cardiac output in response to the
peripheral vasodilatation caused by subarachnoidal blockade, and may develop profound
circulatory collapse which is very difficult to treat.
• Anatomical abnormalities of vertebral column
II. Preoperative
III. Intraoperative
• Fluid preload 15-20 ml/kg via IV canule G20-G18 (0.9%NaCl, R-L or Plasmalyte B
avoid glucose-containing fluids)
• Standard monitoring ( BP every 1min over10, every 2min for the next 10min then
within 5min interval, Ps,SaO2,ECG -continuously)
• Lumbal puncture L2-L3; L3-L4 Use a small needle (27-gauge Quincke or 25-gauge
Whitacre)
• Drugs and Doses Bupivacain5-10mg or Lignocain 20-40mg +/- Pethidine12.5-25mg or
Fentanyl 12.5-25 mcg in 7.5% (5-10%) Dextrose. All medicines should be withdrawn
from ampoules but not flacons
• Supine position with left uterine displacement ( 150 tilted to left operation table or
wedge under right hip)
• Skin sensation test before incision
• Prompt treatment of bradycardia and hypotension with left uterus displacement,
bolus infusion of crystalloid, increments of ephedrine, 5 to 10 mg intravenously as
needed or other vasopressors at a time if necessary and M-cholinomimetics.
• Oxytocin 10 IU IVI when baby has been delivered
• Transfer to recovery room when haemodynamically stable
IV Postoperatively
TREATMENT